Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the biologic imaging reagents market size evolved in recent years?

In recent times, the market size of biologic imaging reagents has witnessed a swift expansion. The market is projected to rise from $18.41 billion in 2024 to $20.26 billion in 2025, with a compound annual growth rate (CAGR) of 10.0%. A variety of factors have led to this growth observed in the historic period. These include an increased frequency of chronic diseases, significant investments in research and development, a trend towards personalized medicine, emphasis on detecting diseases early, a growing elderly population, and partnerships in biomedical research.

What are the predictions for the biologics cdmo market size in the coming years?

There is an anticipation of substantial growth in the size of the biologic imaging reagents market in the coming years. The market is projected to expand to a worth of $27.78 billion in 2029 with a compound annual growth rate (CAGR) of 8.2%. This surge during the forecast period is due to the diversification of applications in drug development, an upswing in demand for molecular imaging, emphasis on non-intrusive diagnostic techniques, worldwide escalation in cancer incidences, and transition towards value-oriented healthcare. Key trends for the forecast period encompass increase in demand for imaging agents enhanced with contrast, development of targeted molecular imaging agents, exploration of nanoparticles for imaging purposes, the advent of fluorescent probes for in vivo imaging, and incorporating artificial intelligence into image analysis.

Get your biologic imaging reagents market report here!

https://www.thebusinessresearchcompany.com/report/biologic-imaging-reagents-global-market-report

What key factors are fueling the growth of the biologic imaging reagents market?

The rise in chronic illnesses is anticipated to boost the biologic imaging reagents market’s expansion. Chronic diseases are long-term conditions that require persistent medical care and may deteriorate over time. Biologic imaging reagents play a crucial role in diagnosing and detecting these diseases by offering a detailed view of organs and impacted structures. For example, the American Cancer Society projected in 2022 that the United States would witness around 1.9 million new cancer diagnoses and 609,360 cancer fatalities. Besides, in January 2023, the National Library of Medicine projected that the number of Americans above 50 years with at least one long-lasting ailment would grow by 99.5%, rising from 71.522 million to 142.66 million by 2050. The escalating prevalence of chronic illnesses is, therefore, a driving force for the biologic imaging reagents market’s growth.

Biologic Imaging Reagents Market Driver: The Significance of Biologic Imaging Reagents in Accelerating the Personalized Medicine Segment

How is the global biologic imaging reagents market divided into key segments?

The biologic imaging reagents market covered in this report is segmented –

1) By Product: Contrast Reagents, Optical Imaging Reagents, Radiopharmaceuticals

2) By Modality: Magnetic Resonance Imaging (MRI), Ultrasound, X-Ray And Computerized Tomography (CT), Nuclear, Optical Imaging, Other Modalities

3) By Application: In Vitro, In Vivo

4) By End User: Diagnostic Laboratories, Imaging Centers, Life Science Companies, Research And Academic Institutes, Other End Users

Subsegments:

1) By Contrast Reagents: X-ray Contrast Agents, MRI Contrast Agents, Ultrasound Contrast Agents

2) By Optical Imaging Reagents: Fluorescent Dyes, Bioluminescent Reagents, Quantum Dots

3) By Radiopharmaceuticals: Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13389&type=smp

Who are the key firms paving the way for growth in the biologic imaging reagents market?

Major companies operating in the biologic imaging reagents market report are Cardinal Health Inc., Johnson And Johnson Services Inc., Bayer Healthcare AG, Thermo Fisher Scientific Inc., Siemens Healthcare GmbH, Dickinson and Company (BD), Koninklijke Philips N.V., GE HealthCare Technologies Inc., Stryker Corporation, FluoroPharma Medical Inc., Lonza Group AG, Illumina Inc., PerkinElmer Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Bracco Diagnostics Inc., Leica Microsystems GmbH, Lantheus Medical Imaging Inc., Guerbet SA, Miltenyi Biotec B.V. and Co. KG, Promega Corporation, Abcam plc., Luminex Corporation, MILabs, LI-COR Biosciences, FUJIFILM VisualSonics Inc., Advanced Proteome Therapeutics Incorporated, BIOPRO Baden-Württemberg GmbH, ABX Advanced Biochemical Compounds GmbH

Which trends are expected to transform the biologic imaging reagents market?

Prominent firms involved in the biologic imaging reagents market are concentrating on creating cutting-edge reagents such as innovative dye technology. This gives researchers and clinicians an additional resource to enhance the sensitivity and specificity of biologic imaging. The development of innovative dye technology involves creating new dyes for various uses, one of them being biological imaging. For example, in April 2022, Becton, Dickinson, and Company, a medical device enterprise from the US, introduced BD Horizon RealYellow 586 Reagents and RealBlue Reagents. This latest line of reagents aids researchers in extracting higher resolution data and more extensive knowledge from samples compared to regular fluorochrome. This is possible because they employ groundbreaking dye technology supervized by artificial intelligence (AI). The AI uses data from the excitation and emission profiles of readily available fluorochromes to pinpoint the most effective areas in laser lines to generate unique dyes.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13389

What regions are contributing significantly to the growth of the biologic imaging reagents market?

North America was the largest region in the biologic imaging reagents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologic imaging reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Cards & Payments Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cards-and-payments-global-market-report

Value Based Care Payment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/value-based-care-payment-global-market-report

M-commerce Payment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/m-commerce-payment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: